Sage Therapeutics Inc (FRA:SG7)
€ 10.175 -0.385 (-3.65%) Market Cap: 589.40 Mil Enterprise Value: -65.07 Mil PE Ratio: 0 PB Ratio: 0.95 GF Score: 49/100

SAGE Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 04:15PM GMT
Release Date Price: €21.8 (+4.81%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Okay. Let's go ahead and get started. Welcome, everyone. This is the fireside chat with Sage Therapeutics. My name is Vikram Purohit, I'm one of the biotech analysts with Morgan Stanley Research. Before we get started, I am going to let you know of a disclosure for all important disclosures, please see the Morgan Stanley website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales representative. With that, happy to have with me Barry Greene from stage. Barry, thanks for joining us.

Barry E. Greene
Sage Therapeutics, Inc. - President, CEO & Director

Yes, Vikram, I really appreciate being here. I thank the organizers of Morgan Stanley for having us. Great to be here in New York with you.

Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Great. Barry, we have quite a few items to talk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot